
Charles P. Coleman
Examiner (ID: 14800, Phone: (571)270-7788 , Office: P/3626 )
| Most Active Art Unit | 3626 |
| Art Unit(s) | 3683, 3626 |
| Total Applications | 604 |
| Issued Applications | 86 |
| Pending Applications | 64 |
| Abandoned Applications | 471 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10367435
[patent_doc_number] => 20150252441
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-10
[patent_title] => 'Biomarkers in Peripheral Blood Mononuclear Cells for Diagnosing or Detecting Lung Cancers'
[patent_app_type] => utility
[patent_app_number] => 14/719826
[patent_app_country] => US
[patent_app_date] => 2015-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 19220
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14719826
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/719826 | Biomarkers in peripheral blood mononuclear cells for diagnosing or detecting lung cancers | May 21, 2015 | Issued |
Array
(
[id] => 11844584
[patent_doc_number] => 09732129
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-08-15
[patent_title] => 'Peptides and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 14/714948
[patent_app_country] => US
[patent_app_date] => 2015-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 10
[patent_no_of_words] => 29470
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14714948
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/714948 | Peptides and uses thereof | May 17, 2015 | Issued |
Array
(
[id] => 10347924
[patent_doc_number] => 20150232930
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-20
[patent_title] => 'USE OF POST-TRANSCRIPTIONAL GENE SILENCING FOR IDENTIFYING NUCLEIC ACID SEQUENCES THAT MODULATE THE FUNCTION OF A CELL'
[patent_app_type] => utility
[patent_app_number] => 14/705433
[patent_app_country] => US
[patent_app_date] => 2015-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 26188
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14705433
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/705433 | USE OF POST-TRANSCRIPTIONAL GENE SILENCING FOR IDENTIFYING NUCLEIC ACID SEQUENCES THAT MODULATE THE FUNCTION OF A CELL | May 5, 2015 | Abandoned |
Array
(
[id] => 10355313
[patent_doc_number] => 20150240319
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-27
[patent_title] => 'Global Analysis of Serum microRNAs as Potential Biomarkers for Lung Adenocarcinoma'
[patent_app_type] => utility
[patent_app_number] => 14/698538
[patent_app_country] => US
[patent_app_date] => 2015-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 10136
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14698538
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/698538 | Global Analysis of Serum microRNAs as Potential Biomarkers for Lung Adenocarcinoma | Apr 27, 2015 | Abandoned |
Array
(
[id] => 11457448
[patent_doc_number] => 20170051354
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-23
[patent_title] => 'EPIGENETIC MODIFICATION OF MAMMALIAN GENOMES USING TARGETED ENDONUCLEASES'
[patent_app_type] => utility
[patent_app_number] => 15/306720
[patent_app_country] => US
[patent_app_date] => 2015-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 19575
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15306720
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/306720 | EPIGENETIC MODIFICATION OF MAMMALIAN GENOMES USING TARGETED ENDONUCLEASES | Apr 23, 2015 | Abandoned |
Array
(
[id] => 11443195
[patent_doc_number] => 20170044216
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-16
[patent_title] => 'COMPOSITIONS AND METHODS TO INCREASE PRODUCTION'
[patent_app_type] => utility
[patent_app_number] => 15/304650
[patent_app_country] => US
[patent_app_date] => 2015-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 27581
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15304650
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/304650 | COMPOSITIONS AND METHODS TO INCREASE PRODUCTION | Apr 19, 2015 | Abandoned |
Array
(
[id] => 10400814
[patent_doc_number] => 20150285823
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-08
[patent_title] => 'COMPOSITIONS AND METHODS RELATED TO DORMANT SENESCENCE-PRONE CELLS (DSPC)'
[patent_app_type] => utility
[patent_app_number] => 14/680540
[patent_app_country] => US
[patent_app_date] => 2015-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 13896
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14680540
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/680540 | COMPOSITIONS AND METHODS RELATED TO DORMANT SENESCENCE-PRONE CELLS (DSPC) | Apr 6, 2015 | Abandoned |
Array
(
[id] => 12017166
[patent_doc_number] => 09809859
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-11-07
[patent_title] => 'Biomarkers for subtypes of cervical cancer'
[patent_app_type] => utility
[patent_app_number] => 14/664346
[patent_app_country] => US
[patent_app_date] => 2015-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 11
[patent_no_of_words] => 27501
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 184
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14664346
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/664346 | Biomarkers for subtypes of cervical cancer | Mar 19, 2015 | Issued |
Array
(
[id] => 10367431
[patent_doc_number] => 20150252436
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-10
[patent_title] => 'METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF CANCER'
[patent_app_type] => utility
[patent_app_number] => 14/661634
[patent_app_country] => US
[patent_app_date] => 2015-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 35
[patent_no_of_words] => 28116
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14661634
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/661634 | METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF CANCER | Mar 17, 2015 | Abandoned |
Array
(
[id] => 10671225
[patent_doc_number] => 20160017369
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-21
[patent_title] => 'VECTOR COMPRISING MULTIPLE HOMOLOGOUS NUCLEOTIDE SEQUENCES'
[patent_app_type] => utility
[patent_app_number] => 14/641669
[patent_app_country] => US
[patent_app_date] => 2015-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 11222
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14641669
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/641669 | Vector comprising multiple homologous nucleotide sequences | Mar 8, 2015 | Issued |
Array
(
[id] => 10353614
[patent_doc_number] => 20150238619
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-27
[patent_title] => 'POLYMERIC CARRIER'
[patent_app_type] => utility
[patent_app_number] => 14/630477
[patent_app_country] => US
[patent_app_date] => 2015-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 41736
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14630477
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/630477 | POLYMERIC CARRIER | Feb 23, 2015 | Abandoned |
Array
(
[id] => 11225340
[patent_doc_number] => 09453054
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-09-27
[patent_title] => 'Modular DNA-binding domains and methods of use'
[patent_app_type] => utility
[patent_app_number] => 14/625698
[patent_app_country] => US
[patent_app_date] => 2015-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 46
[patent_figures_cnt] => 80
[patent_no_of_words] => 32922
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14625698
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/625698 | Modular DNA-binding domains and methods of use | Feb 18, 2015 | Issued |
Array
(
[id] => 11311696
[patent_doc_number] => 20160347806
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-01
[patent_title] => 'OLIGOMERIZATION DOMAIN OF P53 TO BYPASS THE DOMINANT-NEGATIVE EFFECT OF MUTANT'
[patent_app_type] => utility
[patent_app_number] => 15/117042
[patent_app_country] => US
[patent_app_date] => 2015-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 41342
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15117042
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/117042 | OLIGOMERIZATION DOMAIN OF P53 TO BYPASS THE DOMINANT-NEGATIVE EFFECT OF MUTANT | Feb 5, 2015 | Abandoned |
Array
(
[id] => 10272765
[patent_doc_number] => 20150157762
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-11
[patent_title] => 'METHOD FOR BONE FORMATION BY ADMINISTERING POLY(LACTIC-CO-GLYCOLIC ACID) CROSS-LINKED ALENDRONATE'
[patent_app_type] => utility
[patent_app_number] => 14/614718
[patent_app_country] => US
[patent_app_date] => 2015-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 7989
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14614718
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/614718 | Method for bone formation by administering poly(lactic-co-glycolic acid) cross-linked alendronate | Feb 4, 2015 | Issued |
Array
(
[id] => 14948395
[patent_doc_number] => 10435456
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-10-08
[patent_title] => Compositions and methods for increasing the expression and signalling of proteins on cell surfaces
[patent_app_type] => utility
[patent_app_number] => 15/115459
[patent_app_country] => US
[patent_app_date] => 2015-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 20
[patent_no_of_words] => 14075
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15115459
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/115459 | Compositions and methods for increasing the expression and signalling of proteins on cell surfaces | Jan 28, 2015 | Issued |
Array
(
[id] => 10348943
[patent_doc_number] => 20150233949
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-20
[patent_title] => 'DETECTION AND MODULATION OF CYTOCHROME C ACETYLATION'
[patent_app_type] => utility
[patent_app_number] => 14/598813
[patent_app_country] => US
[patent_app_date] => 2015-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 26844
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14598813
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/598813 | DETECTION AND MODULATION OF CYTOCHROME C ACETYLATION | Jan 15, 2015 | Abandoned |
Array
(
[id] => 11873626
[patent_doc_number] => 09745385
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-08-29
[patent_title] => 'Anthropogenic insect-resistant gene and Cry1C toxin idiotype single-chain antibody encoded thereby and application thereof'
[patent_app_type] => utility
[patent_app_number] => 15/025805
[patent_app_country] => US
[patent_app_date] => 2015-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 4020
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15025805
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/025805 | Anthropogenic insect-resistant gene and Cry1C toxin idiotype single-chain antibody encoded thereby and application thereof | Jan 8, 2015 | Issued |
Array
(
[id] => 11364081
[patent_doc_number] => 20170002060
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-01-05
[patent_title] => 'POLYNUCLEOTIDES FOR THE IN VIVO PRODUCTION OF ANTIBODIES'
[patent_app_type] => utility
[patent_app_number] => 15/106000
[patent_app_country] => US
[patent_app_date] => 2015-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 162309
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15106000
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/106000 | POLYNUCLEOTIDES FOR THE IN VIVO PRODUCTION OF ANTIBODIES | Jan 7, 2015 | Abandoned |
Array
(
[id] => 11963858
[patent_doc_number] => 20170268011
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-21
[patent_title] => 'rDNA NTS-BASED GENE MULTIPLE INSERTION CASSETTE SET AND GRAS-GRADE RECOMBINANT YEAST STRAIN'
[patent_app_type] => utility
[patent_app_number] => 15/505252
[patent_app_country] => US
[patent_app_date] => 2014-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 7080
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15505252
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/505252 | rDNA NTS-based gene multiple insertion cassette set and GRAS-grade recombinant yeast strain | Dec 29, 2014 | Issued |
Array
(
[id] => 11348899
[patent_doc_number] => 20160367638
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-22
[patent_title] => 'LEPTIN mRNA COMPOSITIONS AND FORMULATIONS'
[patent_app_type] => utility
[patent_app_number] => 15/104843
[patent_app_country] => US
[patent_app_date] => 2014-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 47486
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15104843
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/104843 | LEPTIN mRNA COMPOSITIONS AND FORMULATIONS | Dec 16, 2014 | Abandoned |